BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Nomura Recommends 'Neutral' On Sun Pharma
As Nomura awaits the details of the 483 observations by the US regulator after inspecting the company's Halol facility, the brokerage has said that given that the number of observations is limited to just three for a large plant inspected over two weeks, this appears to be a good outcome.